Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions

Endocrine Reviews

Volumn 18, Issue 6, 1997, Pages 801-831

  Rajaram, Sujatha ^b   Baylink, David J ^a,c   Mohan, Subburaman ^a,c  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ACROMEGALY; ADULT; AGED; AGING; AMNION FLUID; BODY FLUID; BREAST CANCER; CEREBROSPINAL FLUID; DIABETES MELLITUS; EMBRYO; ENDOMETRIUM CANCER; FETUS; GROWTH HORMONE DEFICIENCY; HUMAN; LYMPH; MILK; NEWBORN; OSTEOPOROSIS; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SEMINAL PLASMA; SERUM; URINE;

AMNIOTIC FLUID; BLOTTING, WESTERN; FEMALE; FOLLICULAR FLUID; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LYMPH; MALE; MILK, HUMAN; PREGNANCY; RADIOIMMUNOASSAY; SEMEN;

EID: 0031442972     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.18.6.801     Document Type: Review

References (349)

1. Shimasaki S, Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243-266
2. Baxter RC, Martin JL 1989 Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1:49-68
3. Rechler MM 1993 Insulin-like growth factor binding proteins. Vitam Horm 47:1-114
4. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
5. Rosenfeld RG, Lamson G, Pham H, Oh Y, Conover C, De Leon DD, Donovan SM, Ocrant I, Giudice L 1990 Insulin-like growth factor-binding proteins. Recent Prog Horm Res 46:99-159
6. Zapf J 1995 Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 132:645-654
7. Lamson G, Giudice LC, Rosenfeld RG 1991 Insulin-like growth factor binding proteins: structural and molecular relationships. Growth Factors 5:19-28
8. Froesch ER, Burgi H, Ramseier EB, Bally P, Labhart A 1963 An tibody-suppressible and non-suppressible insulin-like activities in human serum and their physiologic significance. An insulin assay with adipose tissue of increased precision and specificity. J Clin Invest 42:1816-1834
9. Sterns JS, Antoniades HN, Baile CA, Mayer J 1969 Insulin-like activity in goat serum. Endocrinology 85:976-981
10. Poffenbarger PL, Ensinck JW, Hepp DK, Williams RH 1968 The nature of human serum insulin-like activity (ILA). Characterization of ILA in serum and serum fractions obtained by acid-ethanol and adsorption chromatography. J Clin Invest 47:301-320
11. Daughaday WH, Kipnis DM 1966 The growth promoting and anti-insulin actions of somatotropin. Recent Prog Horm Res 22: 49-99
12. Burgi H, Muller WA, Humbel RE, Froesch ER 1966 Nonsuppress-ible insulin-like activity of human serum. I. Physiochemical properties, extraction and partial purification. Biochim Biophys Acta 121:349-351
13. Hintz RL, Liu F 1977 Demonstrations of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 45:988-995
14. Zapf J, Waldvogel M, Froesch ER 1975 Binding of nonsuppressible insulin-like activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys 168:638-645
15. Kaufmann U, Zapf J, Torretti B, Froesch ER 1977 Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. J Clin Endocrinol Metab 44:160-166
16. Sara VR, Hall K 1990 Insulin-like growth factors and their binding proteins. Physiol Rev 70:591-614
17. Ooi GT, Herington AC 1988 The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors. J Endocrinol 118:7-18
18. Roghani M, Hossenlopp P, Lepage K, Balland A, Binoux M 1989 Isolation from human cerebrospinal fluid of a new insulin-like growth factor binding protein with selective affinity for IGF-II. FEBS Lett 255:253-258
19. Koistinen R, Kalkkinen N, Huhtala M, Seppala M, Bohn H, Rutanen EM 1986 Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin binding protein from human amniotic fluid. Endocrinology 118:1375-1378
20. Drop SL, Valiquette G, Guyda HJ, Corvol MT, Posner BI 1979 Partial purification and characterization of a binding protein for insulin-like activity in human amniotic fluid: a possible inhibitor of insulin-like activity. Acta Endocrinol (Copenh) 90:505-518
21. Donovan SM, Hintz RL, Rosenfeld RG 1995 Investigation into the potential physiological sources of rat milk IGF-I and IGF-binding proteins. J Endocrinol 145:569-578
22. Binoux M, Roghani M, Hossenlopp P, Whitechurch O 1991 Cerebrospinal IGF binding proteins: isolation and characterization. Adv Exp Med Biol 293:161-170
23. Schwander J, Hauri C, Zapf J, Froesch ER 1983 Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused liver in organ culture. Endocrinology 113:297-305
24. Chochinov RH, Mariz IK, Hajek AS, Daughaday WH 1977 Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay. J Clin Endocrinol Metab 44:902-908
25. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC, Rosenfeld RG 1992 Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology 131:3051-3060
26. Bell SC, Patel SR, Jackson JA, Waites GT 1988 Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein. J Endocrinol 118:317-328
27. Mottola C, MacDonald RG, Brackett JL, Mole JE, Anderson JK, Czech MB 1986 Purification and ammo-terminal sequence of an insulin-like growth factor binding protein secreted by rat liver BRL-3A cells. J Biol Chem 261:11180-11188
28. Baxter RC, Martin JL, Tyler MI, Howden MEH 1986 Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. Biochem Biophys Res Commun 139:1256-1261
29. Baxter RC 1988 Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 67:265-272
30. Baxter RC 1990 Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 70:1347-1353
31. Mohan S, Bautista CM, Wergedal J, Baylink DJ 1989 Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci USA 86:8338-8342
32. Shimonaka M, Schroder R, Shimasakai S, Ling N 1989 Identification of a novel binding protein for insulin-like growth factors in adult serum. Biochem Biophys Res Commun 165:1890-1895
33. Shimasakai S, Shimonaka M, Zhang H, Ling N 1991 Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266:10646-10653
34. Bautista CM, Baylink DJ, Mohan S 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756-763
35. Andress DL, Birnbaumer RS 1991 A novel human insulin-like growth factor binding protein secreted by human osteoblast-like cells. Biochem Biophys Res Commun 176:213-218. [Published erratum appears in Biochem Biophys Res Commun 1991 June 14; 177:895.]
36. Camacho-Hubner C, Busby Jr WH, McCusker RH, Wright G, Clemmons DR 1992 Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267: 11949-11956
37. Shimasaki S, Gao L, Shimonaka M, Ling N 1991 Isolation and molecular cloning of insulin-like growth factor-binding protein-6. Mol Endocrinol 5:938-948
38. Martin JL, Willetts KE, Baxter RC 1990 Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem 265:4124-4130
39. Roghani M, Lassarre C, Zapf J, Povoa G, Binoux M 1991 Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J Clin Endocrinol Metab 73:658-666
40. Bach LA, Rechler MM 1996 Measurement of insulin-like growth factor (IGF)-II binding to purified IGF binding proteins 1-6: comparison of charcoal adsorption and high performance size exclusion chromatography. Biochim Biophys Acta 1313:79-88
41. Van Dessel HJHMT, Chandrasekher Y, Yap OWS, Lee PDK, Hintz RL, Faessen GHJ, Brat DDM, Fauser BCJM, Giudice LC 1996 Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol Metab 81:1224-1231
42. Rutanen EM, Seppala M 1992 Insulin-like growth factor binding protein-1 in female reproductive functions. Int J Gynaecol Obstet 39:3-9
43. De Mellow JS, Baxter RC 1988 Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156:199-204
44. Oh Y, Muller HL, Pham H, Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048
45. Jones JI, Gockerman A, Busby Jr WH, Camacho-Hubner C, Clemmons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121:679-687
46. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424-20431
47. Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472
48. Schmid C, Schalpfer I, Froesch ER, Kiefer MC, Zapf J 1993 Insulin-like growth factor binding protein-5 is a mitogen regulated by insulin-like growth factor-I, parathyroid hormone and 1,25-dihydroxyvitamin D3 in vitro. J Bone Miner Res 8:5293 (Abstract)
49. Nicolas V, Mohan S, Honda Y, Prewett A, Finkelman RD, Baylink DJ, Farley JR1995 An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone. Calcif Tissue Int 57:206-212
50. Hayden JM, Mohan S, Baylink DJ 1995 The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93S-98S
51. Jones JI, Gockerman A, Busby Jr WH, Wright G, Clemmons DR 1993 Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90:10553-10557
52. Oh Y, Muller HL, Lamson G, Rosenfeld RG 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 268:14964-14971
53. Cohen P, Lamson G, Okajima T, Rosenfeld RG 1993 Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 7:380-386
54. Rajah R, Valentinis B, Cohen P 1997 Insulin-like growth factor binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-betal on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272: 12181-12188
55. Li WL, Fawcett J, Widmer HR, Fielder PJ, Rabkin R, Keller GA 1997 Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology 138:1763-1766
56. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havemann K 1997 Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 138:1767-1770
57. Guler HP, Zapf J, Schmid C, Froesch ER 1989 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121:753-758
58. Baxter RC 1991 Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr Scand 372:107-114
59. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144
60. Hardouin S, Gourmelen M, Noguiez P, Seurin D, Roghani M, Le Bouc Y, Povoa G, Merimee TJ, Hossenlopp P, Binoux M 1989 Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 69:1291-1301
61. Baxter RC, Cowell CT 1987 Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 65:432-440
62. Martin JL, Baxter RC 1986 Insulin-like growth factor binding protein from human plasma. J Biol Chem 261:8754-8760
63. Zapf J, Schmid C, Guler HP, Waldvogel M, Hauri C, Futo E, Hossenlopp P, Binoux M, Froesch ER 1990 Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults an in patients with extrapancreatic tumor hypoglycemia. J Clin Invest 86:952-961
64. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S, Yokoya S, Nishi Y, Miyamoto S, Sasaki N, Kurimoto F, Stene M, Tsuchiya Y 1994 Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency. Eur J Endocrinol 131:27-32
65. Hasegawa Y, Hasegawa T, Takada M, Tsuchiya Y 1996 Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. Eur J Endocrinol 134:184-189
66. Lewitt MS, Saunders H, Baxter RC 1993 Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 133: 1797-1802
67. Baxter RC, Dai J, Hilman S, Lewitt MS 1994 Determinants of complex formation between IGFBP-3 and acid-labile subunit. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Growth Factors and Their Regulatory Proteins. Elsevier Science, Amsterdam, pp 227-235
68. Baxter RC, Martin JL, Beniac VA 1989 High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J Biol Chem 264:11843-11848
69. Baxter RC, Martin JL 1989 Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc Natl Acad Sci USA 86:6898-6902
70. Lewitt MS, Saunders H, Phuyal JL, Baxter RC 1994 Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. Endocrinology 134:2404-2409
71. 125I]IGF-I. J Clin Endocrinol Metab 80:1318-1324
72. Barreca A, Ponzani P, Arvigo M, Voci A, Giordano G, Minuto F 1995 Functions and regulations of the acid labile subunit of the 150K complex. Prog Growth Factor Res 6:231-239
73. Barreca A, Minuto F 1989 Somatomedins: chemical and functional characteristics of the different molecular forms. J Endocrinol Invest 12:279-294
74. Lee CY, Wu H, Suh D, Rechler MM, Human ICFBP-3 forms binary complexes with endogenous rat acid-labile subunit (ALS) in vivo. Proceedings of The 10th International Congress of Endocrinology, San Francisco, CA, 1996 (Abstract P3-76)
75. Yang YW, Wang JF, Orlowski CC, Nissley SP, Rechler MM 1989 Structure, specificity, and regulation of the insulin-like growth factor-binding proteins in adult rat serum. Endocrinology 125:1540-1555
76. Lee CY, Rechler MM 1995 A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially. Endocrinology 136:668-678
77. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR 1989 Insulin-like growth factor I(IGF-1)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125:766-772
78. Binoux M, Lalou C, Lassarre C, Blat C, Hossenlopp P 1993 Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): a physiological mechanism in the regulation of IGF bioavailability. Adv Exp Med Biol 343:293-300
79. Baxter RC, Suikkari AM, Martin JL 1993 Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum. Biochem J 294:847-852
80. Juul A, Flyvbjerg A, Frystyk J, Müller J, Skakkebaek NE 1996 Serum concentrations of free and total insulin-like growth factor-1, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol (Oxf) 44:515-523
81. Zapf J, Waldvogel M, Froesch ER 1986 Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors-1 in healthy adults. J Clin Invest 77:1768-1775
82. Guler HP, Zapf J, Froesch ER 1987 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137-140
83. Yamamoto H, Murphy LJ 1995 Enzymatic conversion of IGF-I to des(1-3)IGF-I in rat serum and tissues: a further potential site of growth hormone regulation of IGF-I action. J Endocrinol 146:141-148
84. Donovan SM, Odle J 1994 Growth factors in milk as mediators of infant development. Annu Rev Nutr 14:147-167
85. Simmen FA, Simmen RCM, Reinhart G 1988 Maternal and neonatal somatomedin-C/insulin-like growth factor binding proteins during early lactation in the pig. Dev Biol 130:16
86. Skarr TC, Vega JR, Pyke SN, Baumrucker CR 1991 Changes in insulin-like growth factor binding proteins in mammary secretions associated with pregnancy and parturition. J Endocrinol 131:127
87. Suikkari AM 1989 Insulin-like growth factor (IGF-I) and its low molecular weight binding protein in human milk. Eur J Obstet Gynecol Reprod Biol 30:19-25
88. Hasegawa Y, Cohen P, Yorgin P, Rosenfeld RG 1992 Characterization of urinary insulin-like growth factor binding proteins. J Clin Endocrinol Metab 74:830-835
89. Gargosky SE, Hasegawa T, Tapanainen P, MacGillivray M, Hasegawa Y, Rosenfeld RG 1993 Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease. J Clin Endocrinol Metab 76:1631-1637
90. Backstrom M, Hall K, Sara V 1984 Somatomedin level in cerebrospinal fluid from adults with pituitary disorders. Acta Endocrinol (Copenh) 107:171-178
91. Rosenfeld RG, Pham H, Conover CA, Hintz RL, Baxter RC 1989 Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids. J Clin Endocrinol Metab 68:638-646
92. Baxter RC, Saunders H 1992 Radioimmunoassay of insulin-like growth factor binding protein-6 in human serum and other body fluids. J Endocrinol 134:133-139
93. Ocrant I, Fay CT, Parmele JT 1990 Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system. Endocrinology 127:1260-1267
94. Tseng LY, Brown AL, Yang YW, Romanus JA, Orlowski CC, Taylor T, Rechler MM 1989 The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats. Mol Endocrinol 3:1559-1568
95. Muller HL, Oh Y, Gargosky SE, Lehrnbecher T, Hintz RL, Rosenfeld RG 1993 Concentrations of insulin-like growth factor (IGF)-binding protein-3 (1GFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 77:1113-1119
96. Muller HL, Oh Y, Lehrnbecher T, Blum WF, Rosenfeld RG 1994 Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab 79:428-434
97. Nilsson C, Lindvall-Axelsson M, Owman C 1992 Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res Dev 17:109-138
98. Giudice LC, Farrel EM, Pham H, Rosenfeld RG 1990 Identification of insulin-like growth factor binding protein-3 (IGFBP-3) and IGFBP-2 in human follicular fluid. J Clin Endocrinol Metab 71: 1330-1338
99. Cataldo NA, Giudice LC 1992 Insulin-like growth factor binding protein profiles in human ovarian follicular fluid corrrelate with functional status. J Clin Endocrinol Metab 74:821-829
100. Chandrasekher YA, Van Dessel HJ, Fauser BC, Giudice LC 1995 Estrogen- but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease. J Clin Endocrinol Metab 80:2734-2739
101. Giudice LC 1992 Insulin-like growth factors and ovarian follicular development. Endocr Rev 13:641-669
102. Cataldo NA, Giudice LC 1992 Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome. J Clin Endocrinol Metab 74:695-697
103. Adashi EY 1994 Growth factors and ovarian function: the IGF-I paradigm. Horm Res 42:44-48
104. Adashi EY 1993 Intraovarian regulation: the proposed role of insulin-like growth factors. Ann NY Acad Sci 687:10-12
105. Rutanen EM, Koistinen R, Sjoberg J, Julkunen M, Whalstrom T, Bohn H 1986 Synthesis of placental protein 12 by human endometrium. Endocrinology 118:1067-1071
106. Seppala M, Wahlstrom T, Koskimies AL, Tehhunen A, Rutanen EM, Koilstinen R 1984 Human preovulatory follicular fluid, luteinized cells of hyper stimulated and pre-ovulatory follicles, corpus luteum contain placental protein 12. J Clin Endocrinol Metab 58:505-510
107. Adashi EY, Resnick CE, Rosenfeld RG 1994 IGF-I stimulates granulosa cell-derived insulin-like growth factor binding protein-5: evidence for medication via type IIGF receptors. Mol Cell Endocrinol 99:279-284
108. Adashi EY, Resnick CE, Rosenfeld RG, Powell DR, Koistinen R, Rutanen EM, Seppala M 1993 Insulin-like growth factor (IGF) binding protein-1 is an antigonadotropin: evidence that optimal follicle-stimulating hormone action in ovarian granulosa cells is contingent upon amplification by endogenously-derived IGFs. Adv Exp Med Biol 343:377-385
109. Poretsky L, Chandrasekher YA, Bai C, Liu HC, Rosenwaks Z, Giudice L 1996 Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1 (IGFBP-1) production in human granulosa cells. J Clin Endocrinol Metab 81:493-496
110. Chang SY, Hiesch KC, Wang HS, Soong YK 1994 Follicular fluid levels of insulin-like growth factor, insulin-like growth factor binding protein-1 and ovarian steroids collected during ovum pick-up. Fertil Steril 62:1162-1167
111. Wang HS, Lee JD, Soong YK 1995 Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles. Fertil Steril 63: 1204-1209
112. Nobels F, Dewailly D 1992 Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril 58:655-666
113. San Roman GA, Magoffin DA 1992 Insulin-like growth factor binding proteins in healthy and atretic follicles during normal menstrual cycles. J Clin Endocrinol Metab 76:625-632
114. Besnard N, Pisselet C, Zapf J, Hornebeck W, Monniaux D, Monget P 1996 Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor-binding protein levels during growth and atresia of ovine ovarian follicles. Endocrinology 137:1599-1607
115. Nonoshita LD, Wathen NC, Dsupin BA, Chard T, Giudice LC 1994 Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions. J Clin Endocrinol Metab 79:1249-1255
116. Drop SL, Kortleve DJ, Guyda H 1984 Isolation of a somatomedin-binding protein from preterm amniotic fluid: development of a radioimmunoassay. J Clin Endocrinol Metab 59:899-907
117. Bell SC, James PL, Jackson JA, Patel SR, Waites GT, Walczak K 1989 Monoclonal antibodies to human secretory "pregnancy-associated endometrial alpha 1 globulin", an insulin-like growth factor binding protein: characterization and use in radioimmunoassay, western blots and immuno histochemistry. Am J Reprod Immunol 20:87-96
118. Rutanen EM, Bohn H, Seppala M 1982 Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol 144:460-463
119. Claussen M, Zapf J, Braulke T 1994 Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid. Endocrinology 134:1964-1966
120. Binoux M, Hossenlopp P 1988 Insulin-like growth factor (IGF) and IGF binding proteins; human serum and lymph. J Clin Endocrinol Metab 67:509-514
121. Binoux M, Roghani M, Hossenlopp P, Hardouin S, Gourmelen M 1991 Molecular forms of human insulin-like growth factor binding proteins: physiological implications. Acta Endocrinol (Copenh) 124:41-47
122. Cohen P, Peehl DM, Rosenfeld RG 1994 The IGF axis in the prostate. Horm Metab Res 26:81-84
123. Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Huffman AR, Marcus R 1995 Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J Bone Miner Res 10:1844-1852
124. Cohen P, Peehl DM, Graves HC, Rosenfeld RG 1994 Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 142:407-415
125. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75:1046-1053
126. Lee KO, Oh Y, Giudice LC, Cohen P, Peehl DM, Rosenfeld RG 1994 Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients. J Clin Endocrinol Metab 79:1367-1372
127. Peehl DM, Cohen P, Rosenfeld RG 1996 The role of insulin-like growth factors in prostate biology. J Androl 17:2-4
128. Xu S, Cwyfan-Hughes SC, van der Stappen JW, Sansom J, Burton JL, Donnelly M, Holly JM 1995 Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid. J Clin Endocrinol Metab 80:2940-2945
129. Schoen TJ, Waldbillig RJ, Searcy G, Gaudet SJ, Jones BE, Chadar BE, Moshyedi P 1995 Identification and partial characterization of a proteinase specific for insulin-like growth factor binding protein-3 in aqueous and vitreous humors. Curr Eye Res 14:127-135
130. Matsumoto T, Gargosky S, Iwasaki K, Rosenfeld RG 1996 Identification, characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 81:150-155
131. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143
132. Rosenfeld RG, Pham H, Oh Y, Ocrant I 1989 Characterization of insulin-like growth factor binding proteins in cultured rat pituitary cells. Endocrinology 124:2867-2874
133. Rohan RM, Ricciarelli E, Kiefer M, Resnick CE, Adashi EY 1993 Rat ovarian insulin-like growth factor binding protein-6: a hormonally regulated theca-interstitial-selective-species with limited antigonadotrophic activity. Endocrinology 132:2507-2512
134. Srinivasan N, Edwal E, Linkhart TA, Baylink DJ, Mohan S 1996 Insulin-like growth factor binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action. J Endocrinol 149:297-303
135. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab 71:797-805
136. Munoz MT, Barrios V, Pozo J, Argente J 1996 Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications. Pediatr Res 39:992-998
137. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA 1995 Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 80:2282-2288
138. Hall K, Lundin G, Povoa G 1988 Serum levels of low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinol (Copenh) 118: 321-326
139. Honda Y, Landale EC, Strong DD, Baylink DJ, Mohan S 1996 Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab 81:1389-1396
140. Blum W, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Beierich JR 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298
141. Clemmons DR, Snyder DK, Busby Jr WH 1991 Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 73:727-733
142. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink DJ 1995 Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab 80: 2638-2645
143. Blum WF, Horn N, Kratzsch J, Jorgensen JO, Juul A, Teale D, Mohnike K, Ranke MB 1993 Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 3:100-104
144. Schwander J, Mary JL 1993 The RIA for IGFBP-2 in man - a meager catch? The RIA for IGFBP-2 in man - a meager catch? Growth Regul 3:104-108
145. Tonshoff B, Blum WF, Mehls O 1996 Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease. Pediatr Nephrol 10:269-274
146. Powell DR, Liu F, Baker BK, Lee PDK, Hintz RL 1996 Insulin-like growth factor binding proteins growth inhibitors in children with chronic renal failure. Pediatr Nephrol 10:343-347
147. Body JJ, Paesmans M, Sculier JP, Dabouis G, Bureau G, Libert P, Berchier MC, Raymakers N, Klastersky J 1992 Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer. Clin Chem 38:748-751
148. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas P 1992 Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res 7: 1389-1398
149. Mohan S, Baylink DJ 1996 Editorial: Insulin-like growth (IGF)-binding proteins in serum: do they have additional roles besides modulating the endocrine IGF actions. J Clin Endocrinol Metab 81:3817-3820
150. Baxter RC, Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504-1512
151. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 10:68-91
152. Mohan S, Baylink DJ 1995 Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 80:637-647
153. Mohan S 1993 Insulin-like growth factor binding proteins in bone cell regulation. Growth Regul 3:67-70
154. Mohan S, Bautista CM, Herring SJ, Linkhart TA, Baylink DJ 1990 Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. Endocrinology 126:2534-2542
155. Stewart CEH, Rotwein P 1996 Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271:11330-11338
156. Florini JR, Ewton DZ, Magri KA, Mangiacapra FJ 1993 IGFs and muscle differentiation. Adv Exp Med Biol 343:319-326
157. Fowlkes J, Freemark M 1992 Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology 131:2071-2076
158. Conover CA, Kiefer MC, Zapf J 1993 Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J Clin Invest 91:1129-1137
159. Mohan S, Strong DD, Linkhart TA, Baylink DJ 1994 Regulation and actions of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in bone: physiological and clinical implications. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Growth Factors and Their Regulatory Proteins. Exerpta Medica, Amsterdam, pp 205-215
160. Chernausek SD, Smith CE, Duffin KL, Busby WH, Wright G, Clemmons DR 1995 Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4. J Biol Chem 270:11377-11382
161. Young CSJ, Miles MV, Clemmons DR 1992 Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats. Endocrinology 131:1867-1873
162. Thissen JP, Ketelslegers JM, Underwood LE 1994 Nutritional regulation of insulin-like growth factors. Endocr Rev 15:80-101
163. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR 1994 Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 42:145-151
164. Clemmons DR, Underwood LE 1991 Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr 11:393-412
165. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M 1988 Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272
166. Snyder DK, Clemmons DR 1990 Insulin-dependent regulation of insulin-like growth factor-binding protein-1. J Clin Endocrinol Metab 71:1632-1636
167. Holly JMP, Biddlecombe RA, Dunger DB, Edge JA, Arniel SA, Howell R, Chad T, Rees LH, Wass JAH 1988 Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) 29:667-675
168. Yeoh SI, Baxter RC 1988 Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol (Copenh) 119:465-473
169. Busby Jr W, Snyder DK, Clemmons DR 1988 Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor binding protein: control by nutritional variables. J Clin Endocrinol Metab 67: 1225-1230
170. Smith WJ, Underwood LE, Clemmons DR 1995 Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 80:443-449
171. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler Jr GB 1992 The effect of anorexia nervosa and re-feeding on growth hormone-binding protein, the insulin-like growth factors (IGFs) and the IGF binding proteins. J Clin Endocrinol Metab 75:762-767
172. Young SCJ, Underwood LE, Celnicker A, Clemmons DR 1992 Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF binding proteins in calorically restricted adults. J Clin Endocrinol Metab 75:603-608
173. Brismar K, Gutniak M, Povoa G, Werner S, Hall K 1988 Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 11:599-602
174. Breese CR, Ingram RL, Sonntag WE 1991 Influence of age and long term dietary restriction of plasma insulin-like growth factor-I (IGF-I), IGF-I gene expression, and IGF-I binding proteins. J Gerontol 46:B180-B187
175. Hilding A, Brismar K, Thoren M, Hall K 1993 Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes. J Clin Endocrinol Metab 77:1142-1147
176. Straus DS, Takemoto CD 1990 Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and IGF-II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology 127:1849-1860
177. Pucilowska J, Davenport ML, Kabir I, Clemmons DR, Thissen JP, Butler T, Underwood LE 1993 The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF binding proteins in children with shigellosis. J Clin Endocrinol Metab 77: 1516-1521
178. Davies SC, Wass JAH, Ross RJM, Cotterill AM, Buchanan CR, Coulson VJ, Holly JMP 1991 Induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 130:469-473
179. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 71:806-816
180. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE, Clemmons DR 1992 Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab 75:590-595
181. Rasmussen MH, Frystyk J, Anderson T, Breum L, Christiansen JS, Hilsted J 1994 The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-I (IGF-I), IGF binding protein-3, insulin, and growth hormone. Metabolism 43:315-319
182. Rasmussen MH, Juul A, Kjems LL, Skakkebaek NE, Hilsted J 1995 Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J Clin Endocrinol Metab 80:796-801
183. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J, Skakkebaek NE 1995 Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 80:1407-1415
184. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield GE, Hoffman AR, Marcus R 1994 Effect of recombinant growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 79:1361-1366
185. Felsing NE, Brasel JA, Cooper DM 1992 Effect of low- and high intensity exercise on circulating growth hormone in men. J Clin Endocrinol Metab 75:157-162
186. Kraemer WJ, Marchitelli L, Gordon SE 1990 Hormonal and growth factor responses to heavy resistance exercise protocols. J Appl Physiol 69:1442-1450
187. Cappon J, Brasel JA, Mohan S, Cooper DM 1994 Effect of brief exercise on circulating insulin-like growth factor I. J Appl Physiol 76:2490-2496
188. Suikkari AM, Sane T, Seppala M, Yki-Jarvinen H, Karonen SL, Koivisto VA 1989 Prolonged exercise increases serum insulin-like growth factor binding protein concentrations. J Clin Endocrinol Metab 68:141-144
189. Hopkins NJ, Jakeman PM, Cwyfan Hughes SC, Holly JMP 1994 Changes in circulating insulin-like growth factor binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding. J Clin Endocrinol Metab 79:1887-1890
190. Donahue LR, Hunter SJ, Sherblom AP, Rosen CJ 1990 Age-related changes in serum insulin-like growth factor binding proteins in women. J Clin Endocrinol Metab 71:575-579
191. Lamson G, Giudice LC, Cohen P, Liu F, Gargosky S, Muller HL, Oh Y, Wilson KF, Hintz RL, Rosenfeld RG 1993 Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regul 3:91-95
192. Miell JP, Taylor AM, Jones J, Holly JM, Gaillard RC, Pralong FP, Ross RJ, Blum WF 1993 The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF binding proteins in normal male volunteers. J Endocrinol 136:525-533
193. Miell JP, Buchanan CR, Norman MR, Maheshwari HG, Blum WF 1994 The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. J Endocrinol 142:547-554
194. Libanati C, Rajaram S, Baylink DJ, Mohan S 1996 In a longitudinal prospective study, glucocorticoid (GC) therapy causes a marked reduction in bone formation markers and stimulatory insulin-like growth factor (IGF) system components. J Bone Miner Res 11:S150 (Abstract)
195. Han VKM, Matsell DG, Delhanty PJD, Hill DJ, Shimasaki S, Nygard K 1996 IGF-binding protein mRNAs in the human fetus: tissue and cellular distribution of developmental expression. Horm Res 45:160-166
196. Coulter CL, Han VKM 1996 The pattern of expression of insulin-like growth factor (IGF), IGF-I receptor and IGF binding protein (IGFBP) mRNAs in the rhesus monkey placenta suggests a paracrine mode of IGF-IGFBP interaction in placental development. Placenta 17:451-460
197. Green BN, Jones SB, Streck RD, Wood TL, Rotwein P, Pintar JE 1994 Distinct expression of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology 134:954-962
198. Drop SLS, Kortleve DJ, Guyda H, Posner BI 1984 Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal and adult sera. J Clin Endocrinol Metab 79:1249-1255
199. Wang HS, Lim J, English J, Irvine L, Cahrd T 1991 The concentration of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol 129:459-464
200. Giudice L, De Zegher F, Gargosky SE, Dsupin BA, De Las Fuentas L, Crystal RA, Hintz RL, Rosenfeld RG 1995 Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonatal with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548-1555
201. Rajaram S, Carlson SE, Koo WW, Rangachari A, Kelly DP 1995 Insulin-like growth factor (IGF)-I and IGF-binding protein 3 during the first year in term and preterm infants. Pediatr Res 37:581-585
202. Verhaeghe J, van Bree R, van Herck E, Laureys J, Bouillon R, Van Assche FA 1993 C-peptide, the insulin-like growth factors-I and -II, and IGF binding protein-1 in umbilical cord and serum: correlations with birth weight. Am J Obstet Gynecol 169:89-97
203. Lassarre J, Hardouin S, Daftos F, Forestier F, Frakenne F, Binoux M 1994 Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 29:219-225
204. Bang P, Stangenberg M, Westgren M, Rosenfeld RG 1994 Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum. Growth Regul 4:68-76
205. Mohan S, Amarnani S, Baylink DJ 1991 Insulin-like growth factors and their binding proteins: role in pre- and postnatal growth and development. Inland Pediatr 6:1-7
206. Blum WF, Ranke MB 1990 Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3. Acta Paediatr Scand 367:55-62
207. Argente J, Barrios V, Pozo J, Munoz MT, Hervas F, Stene M, Hernandez M 1993 Normative data for insulin-like growth factors (IGFs), IGF binding proteins, and growth hormone binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J Clin Endocrinol Metab 77:1522-1528
208. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NE 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-I, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80:2534-2542
209. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB 1993 Serum levels of insulin-like growth factor 1 (IGF-I) and IGF-binding protein-3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 76:1610-1616
210. Libanati C, Srinivasan N, Baylink DJ, Lois E, Mohan S 1995 Skeletal size increases during Tanner stages II and III: association with a marked upregulation of the serum IGF system. J Bone Miner Res 10:S344 (Abstract)
211. Wang HS, Chard T 1992 Chromatographic characterization of insulin-like growth factor binding proteins in human pregnancy serum. J Endocrinol 133:149-159
212. Gargosky SE, Owens PC, Walton PE, Owens JA, Robinson JS, Wallace JC, Ballard FJ 1991 Most of the circulating insulin-like growth factors-I and -II are present in the 150 kDa complex during pregnancy. J Endocrinol 131:491-497
213. Binoux M, Lalou C, Lassarre C, Segovia B 1994 Regulation of IGF availability by IGFBP proteases. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Growth Factors and Their Regulatory Proteins. Elsevier Science, Amsterdam, pp 217-226
214. Blat C, Villaudy J, Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2286-2290
215. Hasegawa T, Hasegawa Y, Takada M, Tsuchiya Y 1995 The free form of insulin-like growth factor I increases in circulation during normal human pregnancy. J Clin Endocrinol Metab 80:3284-3286
216. Suikkari AM, Baxter RC 1992 Insulin-like growth factor binding protein-3 is functionally normal in pregnancy serum. J Clin Endocrinol Metab 74:177-183
217. Liu F, Baxter RC, Hintz RL 1992 Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum. J Clin Endocrinol Metab 75:1261-1267
218. Langford KS, Nicolaides KH, Jones J, Abbas A, McGregor AM, Miell JP 1995 Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. J Clin Endocrinol Metab 80:21-27
219. Hammerman MR 1987 Insulin-like growth factors and aging. Endocrinol Metab Clin 16:995-1011
220. Florini JR, Prinz PN, Vitiello MV, Hintz RL 1985 Somatomedin-C levels in healthy young and old men: relationship to peak and 24 hour integrated levels of growth hormone. J Gerontol 40:1-7
221. Rudman D, Kutner H, Rogers CM, Lubin MF, Fleming GA, Bain RP 1981 Impaired growth hormone secretion in the adult population. Am Soc Clin Invest 67:1361-1369
222. Mohan S, Farley JR, Baylink DJ 1996 Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging. Prog Growth Factor Res 6:465-473
223. Bennet AE, Wahner HW, Riggs BL, Hintz RL 1984 Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 5:701-704
224. Rutanen EM, Karkkainen T, Stenman UH, Yki-Jarvinen H 1993 Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J Clin Endocrinol Metab 77:1152-1155
225. Fink RI, Kolterman OG, Griffin J, Olefsky JM 1993 Mechanisms of insulin resistance in aging. J Clin Invest 71:1523-1535
226. Morales AJ, Nolan JJ, Nelson JC, Yen SS 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367
227. Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ 1992 The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24-27
228. Ono T, Kanzaki S, Seino Y, Baylink DJ, Mohan S 1996 Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF binding protein-3 and-5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab 81:2111-2116
229. Radetti G, Paganini C, Antoniazzi F, Pasquino B, Valentini R, Gentili L, Tato L 1997 Growth hormone-binding proteins, IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus. Horm Res 47:110-115
230. Gucev ZS, Oh Y, Kelley KM, Labarta JI, Vorwerk P, Rosenfeld RG 1997 Evidence for insulin-like growth factor (IGF)-independent transcriptional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells. Endocrinology 138:1464-1470
231. Mandel S, Moreland E, Nicholas V, Hanna C, Lafrachi S 1991 Changes in insulin-like growth factor-I (IGF-I), IGF binding protein-3, growth hormone (HG) binding protein erythrocyte IGF-I receptors and growth rate during GH treatment. J Clin Endocrinol Metab 80:190-194
232. Mohan S, Baylink DJ 1991 Bone growth factors. Clin Orthop 263: 30-48
233. Powell DR, Lee PD, Suwanichkul A 1993 Multihormonal regulation of IGFBP-1 promoter activity. Adv Exp Med Biol 343:205-214
234. Martin JL, Baxter RC 1991 Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology 128:1425-1433
235. Knutsen R, Honda Y, Strong DD, Sampath TK, Baylink DJ, Mohan S 1995 Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells. Endocrinology 136:857-865
236. Ismail IS, Miell JP, Scanlon MF, Peters JR 1995 Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects. Clin Endocrinol (Oxf) 42:147-152
237. Batch JA, Baxter RC, Werther GA 1991 Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 73:964-968
238. Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha PJ 1997 Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone IGF IGF-binding protein system. J Clin Endocrinol Metab 82:1181-1187
239. Strasser-Vogel B, Blum WF, Past R, Kessler U, Hoeflich A, Meiler B, Kiess W 1995 Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment. J Clin Endocrinol Metab 80:1207-1213
240. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson T A 1995 Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80:1312-1317
241. Frost RA, Bereket A, Wilson TA, Wojnar MM, Lang CH, Gelato MC 1994 Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin-dependent diabetes mellitus and severe trauma. J Clin Endocrinol Metab 78:1533-1535
242. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR 1991 Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA 88:7481-7485
243. Gibson JM, Westwood M, Crosby SR, Gordon C, Holly JMP, Fraser W, Anderson C, White A, Young RJ 1995 Choice of treatment affects plasma insulin-like growth factor binding protein-1 in non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 80:1369-1375
244. Young CSJ, Clemmons DR 1994 Changes in insulin-like growth factor (IGF)-binding proteins after IGF injections in non-insulin-dependent diabetics. J Clin Endocrinol Metab 78:609-614
245. Taylor AM, Dunger DB, Preece MA 1990 The growth hormone independent insulin-like growth factor binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin dependent diabetics. Clin Endocrinol (Oxf) 32:229-239
246. Cwyfan Hughes SC, Johnson MR, Heinrich G 1995 Could abnormalities in insulin-like growth factors and their binding proteins during pregnancy result in gestational diabetes? J Endocrinol 147:517-524
247. Froesch ER, Zapf J 1980 Tumor hypoglycemia and various forms of nonsuppressible insulin-like activity. In: Andreani D, Lefebvre PJ, Marks V (eds) Current Views on Hypoglycemia and Glycogen. Academic Press, New York, pp 163-171
248. Daughaday WH, Emanuelle MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P 1988 Synthesis and secretion of insulin-like growth factor-II by a leimyosarcoma with associated hypoglycemia. N Engl J Med 319:1434-1440
249. Zapf J 1994 Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Horm Res 42: 20-26
250. Zapf J, Schoenle EJ, Waldvogel M, Sand I, Froesch ER 1981 Effect of trypsin-treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors. Further evidence for the action of insulin-like growth factors through the insulin receptor. Eur J Biochem 113:605-609
251. Daughaday WH, Kapadia M 1989 Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 86:6778-6782
252. Daughaday WH, Trivedi B, Baxter RC 1993 Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 90:5823-5827
253. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W 1995 Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 80:2700-2708
254. Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG 1993 Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 76:1031-1035
255. Kanety H, Madjar Y, Dadgan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A 1993 Serum insulin-like growth factor binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostaric cancer: correlation with serum prostate specific antigen. J Clin Endocrinol Metab 77:229-233
256. Cohen P, Peehl DM, Lamson G, Rosenfeld RG 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401-407
257. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB 1986 Secretion of insulin-like growth factor-I related protein by human breast cancer cells. Cancer Res 46:4613-4619
258. Colletti RB, Roberts JD, Devlin JT, Copeland KC 1989 Effects of tamoxifen on plasma insulin-like growth factor-I in patients with breast cancer patients. Cancer Res 49:1881-1884
259. Lonning PE, Hall K, Aakvaag A, Lien EA 1992 Influence of tamoxifen on plasma levels of insulin-like growth factor binding protein-1 in breast cancer patients. Cancer Res 52:4719-4723
260. Taylor AK, Linkhart SG, Mohan S, Baylink DJ 1988 Development of a new radioimmunoassay for human osteocalcin: evidence for a mid-molecule epitope. Metab Clin Exp 37:872-877
261. Zumkeller W, Schwander J, Mitchell CD, Morrell DJ, Schofield PN, Preece MA 1993 Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumor. Eur J Cancer 29A:1973-1977
262. Nivot S, Benelli C, Clot J, Saucet C, Adan L, Souberbielle J, Zucker J, Rappaport R, Brauner R 1994 Non-parallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH binding protein after craniospinal irradiation and chemotherapy. J Clin Endocrinol Metab 78:597-601
263. Cotterill AM, Holly JMP, Taylor AM, Davies SC, Coulson VJ, Preece MA, Wass JA, Savage MO 1992 The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism. J Clin Endocrinol Metab 74:56-63
264. Kanety H, Karasik A, Klinger B, Silbergeld A, Laron Z 1993 Long term treatment of Laron type dwarfs with insulin-like growth factor-I increases serum insulin-like growth factor binding protein-3 in the absence of growth hormone activity. Acta Endocrinol (Copenh) 128:144-149
265. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA, Rosenfeld RG 1993 Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 77:1465-1471
266. Guevara-Aguirre J, Vasconez O, Martinez V, Martinez AL, Rosenbloom AL, Diamond Jr FB, Gargosky SE, Nonoshita L, Rosenfeld RG 1995 A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab 80:1393-1398
267. Tapanainen J, Ronnberg L, Martikainen H, Reinila M, Koistinen R, Seppala M 1991 Short and long term effects of growth hormone on circulating levels of insulin-like growth factor-I (IGF-I), IGF-binding protein-1, and insulin: a placebo-controlled study. J Clin Endocrinol Metab 73:71-74
268. Vaccarello M, Diamond FB, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky SE, Cohen P, Wilson KF, Rosenfeld RG 1993 Hormonal, metabolic, and pharmacokinetic effects of recombinant insulin-like growth factor-1 in growth hormone receptor deficient (GHRD) syndrome. J Clin Endocrinol Metab 77:273-280
269. Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Guevara-Aguirre J, Diamond FB, Baxter RC, Rosenbloom AL, Rosenfeld RG 1993 The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3. J Clin Endocrinol Metab 77:1683-1689
270. Vlachopapadopoulou E, Zachwieja JJ, Gertner JM, Manzione D, Bier DM, Matthews DE, Slonim AE 1995 Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy - a clinical research center study. J Clin Endocrinol Metab 80:3715-3723
271. Backeljauw PF, Underwood LE and The GHIS Collaborative Group 1996 Prolonged treatment with recombinant human insulin-like growth factor-I in children with growth hormone insensitivity syndrome - a clinical research center study. J Clin Endocrinol Metab 81:3312-3317
272. Brismar K, Hilding A, Lindgren B 1995 Regulation of IGFBP-1 in humans. Prog Growth Factor Res 6:449-456
273. Hilding A, Brismar K, Dagerbald M, Thoren M, Hall K 1995 Altered relation between circulating levels of insulin-like growth factor binding protein-1 and insulin in growth hormone deficient and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 80:2646-2552
274. Laron Z, Suikkari AM, Klinger B, Silbergeld A, Pertzelan A, Seppala M, Koivisto VA 1992 Growth hormone and insulin-like growth factor regulate insulin-like growth factor binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutionally short stature. Acta Endocrinol (Copenh) 127:351-358
275. Gargosky SE, Nanto-Salonen K, Tapanainen J, Rosenfeld RG 1993 Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF binding proteins (IGFBPs) and IGFBP protease activity. J Endocrinol 136:479-489
276. Lee DY, Park SK, Yorgin PD, Cohen P, Oh Y, Rosenfeld RG 1994 Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 79:1376-1382
277. Hasegawa Y, Hasegawa T, Koni H, Aso T, Kotoh S, Yamada M, Tsuchiya Y 1995 Proteolytic activity of IGFBP-3 in various clinical conditions during childhood studied by means of western immunoblotting. Endocr J 42:569-576
278. Wilson KF, Fielder PJ, Guevara-Aguirre J, Cohen P, Vasconez O, Martinez V, Martinez A, Rosenbloom AL, Rosenfeld RG 1995 Long-term effects of insulin-like growth factor (IGF)-I treatment on serum IGFs and IGF binding proteins in adolescent patients with growth hormone receptor deficiency. Clin Endocrinol (Oxf) 42: 399-407
279. Gargosky SE, Tapanainen P, Rosenfeld RG 1994 Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats. Endocrinology 134:2267-2276
280. Jorgensen JO, Blum WF, Moller N, Ranke MB, Christiansen JS 1991 Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J Clin Endocrinol Metab 72:582-587
281. Conover CA, Kiefer MC 1993 Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 76:1153-1159
282. Kanzaki S, Hilliker S, Baylink DJ, Mohan S 1994 Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 134:383-392
283. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF 1993 Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52: 222-226
284. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S 1994 Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 9:915-921
285. Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R 1995 Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J Bone Miner Res 10:1844-1852
286. Canalis E 1995 Growth hormone, skeletal growth factors and osteoporosis. Endocr Pract 1:39-43
287. Juul A, Pedersen SA, Sorensen S, Winkler K, Jorgensen JO, Christiansen JS, Skakkebaek NE 1994 Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. Eur J Endocrinol 131:41-49
288. Rosen CJ 1994 Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's Fountain revisited? J Cell Biochem 56:348-356
289. Thoren M, Wivall-Helleryd I, Blum W, Hall K 1994 Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency. Eur J Endocrinol 131:33-40
290. Spagnoli A, Gargosky SE, Spadoni GL, MacGillivray M, Oh Y, Boscherini B, Rosenfeld RG 1995 Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy. J Clin Endocrinol Metab 80:3668-3676
291. De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, Van der Veen E 1996 Monitoring of growth hormone replacement therapy in adults, based on measurements of serum markers. J Clin Endocrinol Metab 81:1371-1377
292. Zapf J, Walther H, Froesch ER 1981 Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 68:1321-1330
293. Grinspoon S, Clemmons D, Swearingen B, Klibanski A 1995 Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab 80:927-932
294. Juul A, Main KM, Blum W, Lindholm E, Ranke MB, Skakkebaek NE 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, -2 and -3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 41:85-93
295. de Herder WW, van der Lely AJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW 1995 IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly. Clin Endocrinol (Oxf) 43:501-505
296. Yoshida T, Shimatsu A, Sakane N, Hizuka N, Horikawa R, Tanaka T 1996 Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: non-pulsative secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels. J Clin Endocrinol Metab 81:310-313
297. Campbell PG, Novak JF 1991 Insulin-like growth factor binding protein inhibits IGF action in human osteosarcoma cells. J Cell Physiol 149:293-300
298. Canalis E, Agnusdei D 1996 Insulin-like growth factors and their role in osteoporosis. Calcif Tissue Int 58:133-134
299. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL 1996 M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12:2003-2009
300. Feyen JHM, Evans DB, Binkert C, Heinrich G, Geiss S, Kocher HP 1991 Recombinant human (cys281) insulin-like growth factor binding protein 2 inhibits both basal and insulin-like growth factor-1 stimulated proliferation and collagen synthesis in fetal rat calvariae. J Biol Chem 266:19469-19474
301. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD 1990 Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. Mol Endocrinol 4:1806-1814
302. Nilsson A, Swolin D, Enerback S, Ohlsson C 1995 Expression of functional growth hormone receptors in cultured human osteoblast-like cells. J Clin Endocrinol Metab 80:3483-3488
303. Ravn K, Overgaard K, Spencer EM, Christiansen C 1995 Insulin-like growth
304. Boonen S, Mohan S, Dequeker J, Aerssens J, Bouillon R, Baylink DJ 1996 Deficit of the serum stimulatory components of insulin-like growth factor system in patients with osteoporosis and femoral neck fracture. J Bone Miner Res 11:S328 (Abstract)
305. Wuster C, Blum W, Sclemilch S, Ranke MB, Ziegler R 1993 Decreased serum insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 234:249-255
306. Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen EF 1994 No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis. Eur J Endocrinol 131:150-155
307. Scharla SH, Strong DD, Rosen C, Mohan S, Holick M, Baylink DJ, Linkhart TA 1993 1,25-Dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo. J Clin Endocrinol Metab 77:1190-1197
308. Scharla SH, Strong DD, Mohan S, Baylink DJ, Linkhart TA 1991 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129:3139-3146
309. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts Jr CT, Fontana JA 1994 Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158:69-78
310. Goldberg AC, Trivedi B, Deimez JA, Harter HR, Daughaday WH 1982 Uremia reduces serum insulin-like growth factor-I, increases insulin-like growth factor-II, and modifies their serum protein binding. J Clin Endocrinol Metab 55:1040-1045
311. Liu F, Powell DR, Hintz RL 1990 Insulin-like growth factor binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 70:620-628
312. Lee PD, Hintz RL, Sperry JB, Baxter RC, Powell DR 1989 IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr Res 26:308-315
313. Tonshoff B, Blum WF, Wingen AM, Mehls O 1995 Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Clin Endocrinol Metab 80:2684-2691
314. Tonshoff B, Mehls O, Heinrich G, Blum WF, Ranke MB, Schauer A 1990 Growth stimulating effects of recombinant human growth hormone in children with end stage renal disease. J Pediatr 116: 561-566
315. Gourmelen M, Girard F, Binoux M 1982 Serum somatomedin/ insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy. J Clin Endocrinol Metab 54:885-891
316. Broyer M, Guest G 1989 Growth after transplantation: a single center experience. In: Scharer K (ed) Pediatric and Adolescent Endocrinology. Karger, Basel, pp 36-45
317. Hirschberg R, Kaysen GA 1995 Insulin-like growth factor I and its binding proteins in the experimental nephrotic syndrome. Endocrinology 136:1565-1571
318. Powell DR, Liu F, Baker B, Lee PD, Belsha CW, Brewer ED, Hintz RL 1993 Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 33:136-143
319. Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH 1995 Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 80:1148-1157
320. Ross RJM, Rodriguez-Arnao J, Donaghy A 1994 Expression of IGFBP-I in normal and cirrhotic human livers. J Endocrinol 141: 377-382
321. Holt RI, Jones JS, Stone NM, Baker AJ, Miell JP 1996 Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation. J Clin Endocrinol Metab 81:160-168
322. Cwyfan Hughes SC, Cotterill AM, Molloy AR, Cassell TB, Braude N, Hinds CJ, Wass JAH, Holly JMP 1992 The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol 135:135-145
323. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJM, Valcavi R 1993 Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF binding proteins. J Clin Endocrinol Metab 76:950-955
324. Angervo M, Tiihonen M, Leinonen P, Valimaki M, Seppala M 1993 Thyroxine treatment increases circulating levels of insulin-like growth factor binding protein-1: a placebo controlled study. Clin Endocrinol (Oxf) 38:547-551
325. Giudice LC 1995 IGF binding protein-3 protease regulation: how sweet it is. J Clin Endocrinol Metab 80:2279-2281
326. Irwin JC, Kirk D, Gwatkin RB, Navre M, Cannon P, Giudice LC 1996 Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 97:438-447
327. Collett-Solberg PF, Cohen P 1996 The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 25:591-614
328. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H 1994 Matrix metal-loproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269:25742-25746
329. Nam TJ, Busby Jr WH, Clemmons DR 1994 Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology 135:1385-1391
330. Durham SK, De Leon DD, Okazaki R, Riggs BL, Conover CA 1995 Regulation of insulin-like growth factor (IGF)-binding protein-4 availability in normal human osteoblast-like cells: role of endogenous IGFs. J Clin Endocrinol Metab 80:104-110
331. Durham SK, Riggs BL, Conover CA 1994 The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. J Clin Endocrinol Metab 79:1752-1758
332. Parker A, Gockerman A, Busby WH, Clemmons DR 1995 Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology 136:2470-2476
333. Xu S, Cwyfan-Hughes SC, van der Stappen JW, Sansom J, Burton JL, Donnelly M, Holly JM 1996 Altered insulin-like growth factor-II (IGF-II) level and IGF-binding protein-3 (IGFBP-3) protease activity in interstitial fluid taken from the skin lesion of psoriasis. J Invest Dermatol 106:109-112
334. Plymate SR, Rosen CJ, Paulsen CA, Ware JL, Chen JZ, Vessella RE, Birnbaum RS 1996 Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract. J Clin Endocrinol Metab 81:618-624
335. Bang P, Brismar K, Rosenfeld RG 1994 Increased proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) in non-insulin dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated iGFBP-3 contained in the approximately 130-150 kDa ternary complex. J Clin Endocrinol Metab 78:1119-1127
336. Bang P 1995 Serum proteolysis of IGFBP-3. Prog Growth Factor Res 6:285-292
337. Fowlkes J, Thrailkill KM, Serra DM, Suzuki K, Nagase H 1995 Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 6:255-263
338. Rajah R, Katz L, Nunn S, Solberg P, Beers T, Cohen P 1995 Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. Prog Growth Factor Res 6:273-284
339. Hughes SCC, Xu S, Fernihough J, Hampton A, Mason HD, Franks S, Stappen VD, Donnelly M, Holly JMP 1995 Tissue IGFBP-3 proteolysis: contrasting pathophysiology to that in the circulation. Prog Growth Factor Res 6:293-299
340. Conover CA 1995 Insulin-like growth factor binding protein proteolysis in bone cell models. Prog Growth Factor Res 6:301-309
341. Braulke T, Claussen M, Saftig P, Wendland M, Neifer K, Schmidt B, Zapf J, Figura K, Peters C 1995 Proteolysis of IGFBP-3 by cathepsin D in vitro and in cathepsin D-deficient mice. Prog Growth Factor Res 6:265-271
342. Clemmons DR, Busby WH, Arai T, Nam TJ, Clarke JB, Jones JI, Ankrapp K 1995 Role of insulin-like growth factor binding proteins in the control of IGF action. Prog Growth Factor Res 6:357-366
343. Donnelly MJ, Holly JMP 1996 The role of IGFBP-3 in the regulation of IGFBP-4 proteolysis. J Endocrinol 149:R1-R7
344. Bagi C, van der Meulen M, Brommage R, Rosen D, Sommer A 1995 The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats. Bone 16:559-565
345. Bagi CM, Brommage R, Deleon L, Adams S, Rosen D, Sommer A 1994 Benefit of systemically administered rhIGF-I and rhIGF-I/ IGFBP-3 on cancellous bone in ovariectomized rats. J Bone Miner Res 9:1301-1312
346. Bar RS, Clemmons DR, Boes M, Busby WH, Booth BA, Dake BL, Sandra A 1990 Transcapillary and sub-endothelial distribution of endothelial and amniotic fluid IGF binding proteins in rat heart. Endocrinology 127:1078-1086
347. Thrailkill KM, Quarles LD, Nagase H, Suzuki K, Serra DM, Fowlkes JL 1995 Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527-3533
348. Fowlkes JL, Serra DM, Rosenberg CK, Thrailkill KM 1995 Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem 270:27481-27488
349. Oh YM, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG 1996 Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7 - recombinant human mac25 protein specifically binds IGF-I and II. J Biol Chem 271:30322-30325